BPG is committed to discovery and dissemination of knowledge
Article Citation
Niranjan MR, Srinivasa S, Gupta V, Bhalla AK, Gaikwad A, Wangikar P, Suryawanshi S, Gajbe P. Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study. World J Nephrol 2025; 14(2): 100117 [PMID: 40568335 DOI: 10.5527/wjn.v14.i2.100117]
Please LOGIN to submit a new comment.
Write to the Help Desk